Innovid (CTV)
(Delayed Data from NYSE)
$2.34 USD
+0.06 (2.63%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.32 -0.02 (-0.85%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth NA Momentum NA VGM
Income Statements
Fiscal Year end for Innovid Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 140 | 127 | 90 | 0 | 56 |
Cost Of Goods | 34 | 30 | 18 | 0 | 11 |
Gross Profit | 106 | 97 | 73 | 0 | 46 |
Selling & Adminstrative & Depr. & Amort Expenses | 139 | 127 | 78 | 0 | 52 |
Income After Depreciation & Amortization | -33 | -30 | -6 | 0 | -6 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | -3 | -13 | 4 | 0 | 0 |
Pretax Income | -30 | -16 | -10 | 0 | -6 |
Income Taxes | 2 | 2 | 1 | 0 | 1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -32 | -18 | -11 | 0 | -7 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -32 | -18 | -11 | 0 | -7 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -5 | -24 | -5 | 0 | -6 |
Depreciation & Amortization (Cash Flow) | 28 | 6 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -33 | -30 | -6 | 0 | -6 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 138.58 | 130.76 | 26.75 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.12 | -0.11 | -3.03 | NA | NA |
Diluted Net EPS (GAAP) | -0.23 | -0.14 | -3.31 | NA | NA |
Fiscal Year end for Innovid Corp falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 38.62 | 36.23 | 34.55 | 30.49 |
Cost Of Goods | NA | 8.52 | 8.43 | 8.59 | 8.27 |
Gross Profit | NA | 30.10 | 27.81 | 25.96 | 22.22 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 32.65 | 32.13 | 43.83 | 30.44 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.55 | -4.32 | -17.87 | -8.22 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | -0.41 | -0.29 | -0.25 | -2.48 |
Pretax Income | NA | -2.14 | -4.03 | -17.62 | -5.74 |
Income Taxes | NA | -0.48 | -1.30 | 1.34 | 2.82 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.66 | -2.73 | -18.96 | -8.56 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.66 | -2.73 | -18.96 | -8.56 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 140.77 | 139.61 | 137.64 | 136.01 |
Diluted EPS Before Non-Recurring Items | NA | -0.01 | -0.02 | -0.03 | -0.06 |
Diluted Net EPS (GAAP) | NA | -0.01 | -0.02 | -0.14 | -0.06 |